$229 Million is the total value of Prosight Management, LP's 38 reported holdings in Q1 2019. The portfolio turnover from Q4 2018 to Q1 2019 was 34.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HNGR | Sell | HANGER INC | $17,784,000 | -21.1% | 933,548 | -21.5% | 7.78% | -33.1% |
| RETA | Sell | REATA PHARMACEUTICALS INCcl a | $15,017,000 | +5.8% | 175,700 | -30.6% | 6.57% | -10.3% |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $11,320,000 | +4.7% | 252,500 | -9.1% | 4.95% | -11.3% |
| WCG | Sell | WELLCARE HEALTH PLANS INC | $10,979,000 | -7.0% | 40,700 | -18.6% | 4.80% | -21.2% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $8,721,000 | -7.3% | 917,080 | -13.7% | 3.82% | -21.4% |
| ALBO | Sell | ALBIREO PHARMA INC | $8,691,000 | +31.1% | 269,836 | -0.1% | 3.80% | +11.2% |
| BMRN | Sell | BIOMARIN PHARMACEUTICAL INC | $5,097,000 | -41.9% | 57,384 | -44.3% | 2.23% | -50.8% |
| SBBP | Sell | STRONGBRIDGE BIOPHARMA PLC | $4,651,000 | +10.7% | 933,876 | -0.4% | 2.04% | -6.2% |
| SRRA | Sell | SIERRA ONCOLOGY INC | $4,203,000 | +24.7% | 2,457,683 | -3.8% | 1.84% | +5.7% |
| Sell | INTEC PHARMA LTD JERUSALEM | $3,980,000 | -21.9% | 542,919 | -19.7% | 1.74% | -33.9% | |
| TLGT | Sell | TELIGENT INC NEW | $3,528,000 | -27.4% | 3,041,568 | -14.3% | 1.54% | -38.5% |
| PRSC | Sell | PROVIDENCE SVC CORP | $3,486,000 | -25.8% | 52,324 | -33.2% | 1.52% | -37.1% |
| KURA | Sell | KURA ONCOLOGY INC | $2,868,000 | -35.5% | 172,894 | -45.4% | 1.26% | -45.3% |
| MGNX | Sell | MACROGENICS INC | $1,934,000 | -21.5% | 107,560 | -44.6% | 0.85% | -33.5% |
| CERC | Sell | CERECOR INC | $665,000 | -33.1% | 113,835 | -63.0% | 0.29% | -43.3% |
| CDTX | Sell | CIDARA THERAPEUTICS INC | $584,000 | +1.0% | 220,264 | -10.4% | 0.26% | -14.1% |
| AQXP | Sell | AQUINOX PHARMACEUTICALS INC | $76,000 | -56.1% | 28,300 | -64.8% | 0.03% | -62.9% |
| OPTN | Exit | OPTINOSE INC | $0 | – | -140,314 | -100.0% | -0.45% | – |
| PIRS | Exit | PIERIS PHARMACEUTICALS INC | $0 | – | -332,846 | -100.0% | -0.46% | – |
| GTS | Exit | TRIPLE-S MGMT CORPcl b | $0 | – | -65,515 | -100.0% | -0.59% | – |
| LGND | Exit | LIGAND PHARMACEUTICALS INC | $0 | – | -12,600 | -100.0% | -0.88% | – |
| EOLS | Exit | EVOLUS INC | $0 | – | -195,911 | -100.0% | -1.20% | – |
| AXGN | Exit | AXOGEN INC | $0 | – | -209,088 | -100.0% | -2.20% | – |
| VKTX | Exit | VIKING THERAPEUTICS INC | $0 | – | -624,000 | -100.0% | -2.46% | – |
| GLPG | Exit | GALAPAGOS NVspon adr | $0 | – | -62,850 | -100.0% | -2.98% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -61,400 | -100.0% | -4.24% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ALDEYRA THERAPEUTICS INC | 19 | Q2 2023 | 6.2% |
| ALBIREO PHARMA INC | 18 | Q4 2022 | 9.2% |
| MEIRAGTX HOLDINGS PLC | 18 | Q3 2023 | 6.3% |
| KEZAR LIFE SCIENCES INC | 17 | Q3 2023 | 8.2% |
| ARENA PHARMACEUTICALS INC | 16 | Q4 2021 | 8.2% |
| IOVANCE BIOTHERAPEUTICS INC | 16 | Q1 2022 | 7.7% |
| CENTENE CORP DEL | 16 | Q3 2023 | 5.3% |
| CUE BIOPHARMA INC | 14 | Q1 2023 | 5.6% |
| PROTHENA CORP PLC | 13 | Q3 2023 | 13.6% |
| ZIMMER BIOMET HOLDINGS INC | 13 | Q3 2021 | 9.8% |
View Prosight Management, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| EXICURE, INC. | February 14, 2022 | 2,426,508 | 2.2% |
| Aldeyra Therapeutics, Inc. | February 12, 2021 | 908,488 | 2.3% |
| Teligent, Inc. | February 14, 2020 | 1,484,527 | 2.8% |
| Cidara Therapeutics, Inc. | February 14, 2019 | 245,764 | 0.9% |
| Eiger BioPharmaceuticals, Inc.Sold out | February 14, 2019 | 0 | 0.0% |
| Millendo Therapeutics, Inc. | February 14, 2019 | 256,739 | 2.0% |
| OvaScience, Inc. | October 26, 2018 | 1,991,100 | 5.6% |
| CHIMERIX INC | February 13, 2018 | 1,478,519 | 3.1% |
| Harvard Apparatus Regenerative Technology, Inc. | February 12, 2016 | 184,360 | 1.4% |
View Prosight Management, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G | 2024-05-03 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G | 2024-01-02 |
View Prosight Management, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.